The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine

por Kantor, Ariel, Haga, Susanne B.
Publicado 2021

CRISPR-Cas9 DNA Base-Editing and Prime-Editing

por Kantor, Ariel, McClements, Michelle E., MacLaren, Robert E.
Publicado 2020

Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations

por Salman, Ahmed, Kantor, Ariel, McClements, Michelle E., Marfany, Gemma, Trigueros, Sonia, MacLaren, Robert E.
Publicado 2022

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?

por Han, Ruofan Connie, Fry, Lewis E., Kantor, Ariel, McClements, Michelle E., Xue, Kanmin, MacLaren, Robert E.
Publicado 2021

Genome-Editing Strategies for Treating Human Retinal Degenerations

por Quinn, Joel, Musa, Ayesha, Kantor, Ariel, McClements, Michelle E., Cehajic-Kapetanovic, Jasmina, MacLaren, Robert E., Xue, Kanmin
Publicado 2021

Transgenic mice for in vivo epigenome editing with CRISPR-based systems

por Gemberling, Matthew P., Siklenka, Keith, Rodriguez, Erica, Tonn-Eisinger, Katherine R., Barrera, Alejandro, Liu, Fang, Kantor, Ariel, Li, Liqing, Cigliola, Valentina, Hazlett, Mariah F., Williams, Courtney A., Bartelt, Luke C., Madigan, Victoria J., Bodle, Josephine C., Daniels, Heather, Rouse, Douglas C., Hilton, Isaac B., Asokan, Aravind, Ciofani, Maria, Poss, Kenneth D., Reddy, Timothy E., West, Anne E., Gersbach, Charles A.
Publicado 2021